Also found in: Medical.
FEIBAFactor Eight Inhibitor Bypassing Activity (freeze-dried, sterile, human plasma fraction used to aid in coagulation)
References in periodicals archive ?
1 en el periodo preprofilaxis y de 1 despues de 12 meses de profilaxis con FEIBA.
It was reported on Friday that Baxter International, a United States-based healthcare company, has received approval for its FEIBA (Anti-Inhibitor Coagulant Complex) from the US Food and Drug Administration.
Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in hemophilia patients with inhibitors: results from FEIBA NF prophylaxis study.
We do not recommend redosing the 4-factor PCC, nor do we recommend providing rFVIIa or FEIBA within 24 hours of a dose of the 4-factor PCC owing to our concern for possible thromboembolic complications.
Diversified healthcare company Baxter International Inc (NYSE:BAX) announced on Thursday grant of approval by the US Food and Drug Administration (FDA) for its FEIBA [Anti-Inhibitor Coagulant Complex].
M2 PHARMA-December 20, 2013-Baxter's FEIBA receives US FDA approval for FEIBA for prophylactic treatment of haemophilia patients with inhibitors
Belirtilmesine ragmen ameliyat sonrasi sargi bezi ve pansumanin acilmasi sirasinda saglanan hemostaz bozuldu ve ardisik tedavi 12 ve 18 gun devam etti (birinci hastada 14,4 gr rFVIIa ve 76 000 U FEIBA, ikinci hastada 6 gr rFVIIa ve 25 500 U FEIBA kullanildi).
7 billion, up 8%, driven primarily by double-digit growth and continued strong demand for hemophilia therapies (+11% to $942 million), including ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] and FEIBA (an inhibitor therapy).
M2 EQUITYBITES-March 4, 2013-Baxter submits biologics license application supplement for prophylaxis treatment of FEIBA NF(C)2013 M2 COMMUNICATIONS http://www.